Lead territory commercialization of gedatolisib, a groundbreaking therapy for advanced breast cancer.
Base: $185,000-$215,000; Bonus/Equity: Annual performance incentive bonus and new hire equity package; Benefits: Medical, dental, vision insurance, 401(k) match, PTO, paid holidays
Must-have
Nice-to-have
Not specified